VISINE DRY EYE RELIEF- glycerin, hypromelloses, and polyethylene glycol 400 solution/ drops

Visine Dry Eye Relief by

Drug Labeling and Warnings

Visine Dry Eye Relief by is a Otc medication manufactured, distributed, or labeled by Johnson & Johnson Consumer Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

ACTIVE INGREDIENT

Active ingredients	Purpose
Glycerin 0.2%	Lubricant
Hypromellose 0.2%	Lubricant
Polyethylene glycol 400 1%	Lubricant

Use

• for the temporary relief of burning and irritation due to dryness of the eye
• for protection against further irritation

Warnings

For external use only

When using this product

• remove contact lenses before using
• do not use if this solution changes color or becomes cloudy
• do not touch tip of container to any surface to avoid contamination
• replace cap after each use

Stop use and ask a doctor if

• you feel eye pain
• changes in vision occur
• redness or irritation of the eye lasts
• condition worsens or lasts more than 72 hours

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• put 1 to 2 drops in the affected eye(s) as needed
• children under 6 years of age: ask a doctor

Other information

• store at 15° to 25°C (59° to 77°F)

Inactive ingredients

Ascorbic Acid, Benzalkonium Chloride, Boric Acid, Dextrose, Disodium Phosphate, Glycine, Magnesium Chloride, Potassium Chloride, Purified Water, Sodium Borate, Sodium Chloride, Sodium Citrate, Sodium Lactate

Questions?

call toll-free 888-734-7648; or 215-273-8755 (collect)

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

Sterile
Visine®

DRY EYE
Relief
LUBRICANT EYE DROPS

Relieves
burning,
gritty,
irritated
DRY EYES

1/2 FL. OZ. (15 mL)

INGREDIENTS AND APPEARANCE

VISINE DRY EYE RELIEF 
glycerin, hypromelloses, and polyethylene glycol 400 solution/ drops

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 42002-210
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Glycerin (UNII: PDC6A3C0OX) (Glycerin - UNII:PDC6A3C0OX)	Glycerin	2 mg  in 1 mL
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) (HYPROMELLOSE, UNSPECIFIED - UNII:3NXW29V3WO)	HYPROMELLOSE, UNSPECIFIED	2 mg  in 1 mL
Polyethylene Glycol 400 (UNII: B697894SGQ) (Polyethylene Glycol 400 - UNII:B697894SGQ)	Polyethylene Glycol 400	10 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
Ascorbic Acid (UNII: PQ6CK8PD0R)
Benzalkonium Chloride (UNII: F5UM2KM3W7)
Boric Acid (UNII: R57ZHV85D4)
Dextrose, Unspecified Form (UNII: IY9XDZ35W2)
Sodium Phosphate, Dibasic, Anhydrous (UNII: 22ADO53M6F)
Glycine (UNII: TE7660XO1C)
Magnesium Chloride (UNII: 02F3473H9O)
Potassium Chloride (UNII: 660YQ98I10)
Water (UNII: 059QF0KO0R)
Sodium Borate (UNII: 91MBZ8H3QO)
Sodium Chloride (UNII: 451W47IQ8X)
Sodium Citrate, Unspecified Form (UNII: 1Q73Q2JULR)
Sodium Lactate (UNII: TU7HW0W0QT)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 42002-210-05	1 in 1 CARTON	06/05/2009	06/01/2021
1		15 mL in 1 BOTTLE, DROPPER; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
2	NDC: 42002-210-02	2 in 1 CARTON	06/05/2009	06/01/2021
2	NDC: 42002-210-05	1 in 1 CARTON
2		15 mL in 1 BOTTLE, DROPPER; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH FINAL	part349	06/05/2009	06/01/2021

Labeler - Johnson & Johnson Consumer Inc. (002347102)